Skip to main content
. 2014 Jan 3;18(4):421–433. doi: 10.1016/j.bjid.2013.10.005

Fig. 1.

Fig. 1

Frequency of ESBL producers among E. coli and K. pneumoniae isolates in the SMART and TEST antimicrobial surveillance programs.8, 27, 28, 31, 36 *United States data only. DISN, Doripenem International Surveillance Network; ESBL, extended spectrum β-lactamase; SMART, Study for Monitoring Antimicrobial Resistance Trends; TEST, Tigecycline Evaluation and Surveillance Trial.